|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4708713A
(en)
|
1984-11-16 |
1987-11-24 |
Anisa Medical, Inc. |
Method and system for removing immunosuppressive components from the blood of mammals
|
|
EP0236509B1
(en)
|
1985-09-19 |
1993-02-10 |
Toray Industries, Inc. |
B2-microglobulin-removing column
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
ES2048191T3
(es)
|
1987-12-11 |
1994-03-16 |
Akzo Nv |
Membrana de dialisis biocompatible a base de celulosa con adsorcion incrementada de beta-2-microglobulina.
|
|
DE69033982T2
(de)
|
1989-03-21 |
2002-10-24 |
The United States Of America, Represented By The Secretary |
Matrizenmetalloproteinase-inhibitor-peptide
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
US5240614A
(en)
|
1992-01-10 |
1993-08-31 |
Baxter International Inc. |
Process for removing unwanted materials from fluids and for producing biological products
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US6544761B2
(en)
*
|
1994-12-13 |
2003-04-08 |
Human Genome Sciences, Inc. |
Human tissue inhibitor of metalloproteinase-4
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
GB9607287D0
(en)
|
1996-04-09 |
1996-06-12 |
British Biotech Pharm |
Diagnosis method
|
|
ATE252369T1
(de)
|
1996-08-09 |
2003-11-15 |
Alcon Mfg Ltd |
Konservierungssysteme fur cyclodextrine enthaltende arzneimittel
|
|
US5916202A
(en)
|
1996-08-30 |
1999-06-29 |
Haswell; John N. |
Umbilical cord blood collection
|
|
US6022948A
(en)
*
|
1996-09-17 |
2000-02-08 |
Washington University |
Method of cell surface activation and inhibition
|
|
US20020159995A1
(en)
|
1997-07-30 |
2002-10-31 |
Renal Tech International |
Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
|
|
US5904663A
(en)
|
1997-07-30 |
1999-05-18 |
Braverman; Andrew |
Method of removing beta-2 microglobulin from blood
|
|
US6416487B1
(en)
|
1997-07-30 |
2002-07-09 |
Renal Tech International Llc |
Method of removing beta-2 microglobulin from blood
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
AUPP790898A0
(en)
|
1998-12-23 |
1999-01-28 |
Life Therapeutics Limited |
Renal dialysis
|
|
AUPR748501A0
(en)
|
2001-09-04 |
2001-09-27 |
Life Therapeutics Limited |
Renal dialysis
|
|
WO2000040749A2
(en)
|
1999-01-06 |
2000-07-13 |
Genenews Inc. |
Method for the detection of gene transcripts in blood and uses thereof
|
|
AU1923200A
(en)
|
1999-01-22 |
2000-08-07 |
Dow Chemical Company, The |
Surface modified divinylbenzene resin having a hemocompatible coating
|
|
JP4342027B2
(ja)
*
|
1999-04-01 |
2009-10-14 |
オリエンタル酵母工業株式会社 |
Ｔｉｍｐ修飾体
|
|
UA35656C2
(uk)
|
1999-12-27 |
2001-04-16 |
Олександр Миколайович Макаренко |
Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань
|
|
US7582292B2
(en)
|
2000-02-26 |
2009-09-01 |
Artecel, Inc. |
Adipose tissue derived stromal cells for the treatment of neurological disorders
|
|
US6946546B2
(en)
|
2000-03-06 |
2005-09-20 |
Cambridge Antibody Technology Limited |
Human antibodies against eotaxin
|
|
GB0015761D0
(en)
|
2000-06-27 |
2000-08-16 |
Univ Bristol |
Polypeptide
|
|
US6632174B1
(en)
|
2000-07-06 |
2003-10-14 |
Cognifit Ltd (Naiot) |
Method and apparatus for testing and training cognitive ability
|
|
US20020151064A1
(en)
|
2001-02-07 |
2002-10-17 |
Children's Hospital Medical Center |
Regulation of CCR3 expression
|
|
US6475161B2
(en)
|
2001-03-29 |
2002-11-05 |
The Mclean Hospital Corporation |
Methods for diagnosing Alzheimer's disease and other forms of dementia
|
|
WO2003006006A1
(en)
|
2001-07-09 |
2003-01-23 |
The Regents Of The University Of California |
Use of matrix metalloproteinase inhibitors to mitigate nerve damage
|
|
US20050071088A1
(en)
|
2001-08-13 |
2005-03-31 |
Landfield Philip W |
Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
|
|
US6906036B2
(en)
|
2001-08-16 |
2005-06-14 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US7608406B2
(en)
|
2001-08-20 |
2009-10-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
|
US20050048035A1
(en)
|
2001-12-07 |
2005-03-03 |
Fraser John K. |
Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
|
|
KR100441384B1
(ko)
|
2002-01-08 |
2004-07-21 |
주식회사 안지오랩 |
인간 혈청 알부민-팀프-2 융합 단백질 발현시스템 및재조합 인간 혈청 알부민-팀프-2 융합 단백질
|
|
WO2003094950A2
(en)
|
2002-05-10 |
2003-11-20 |
Ipf Pharmaceuticals Gmbh |
A method of inhibiting the emigration of cells from the intravascular compartment into tissues
|
|
DK1953556T3
(da)
|
2002-08-23 |
2010-10-25 |
Bayer Schering Pharma Ag |
Polypeptidbiomarkører til diagnose af Alzheimer's sygdom
|
|
EP1394549A1
(en)
|
2002-08-23 |
2004-03-03 |
Bayer HealthCare AG |
Biomarkers for diagnosing Alzheimer's disease
|
|
US20040127445A1
(en)
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
US20050244448A1
(en)
*
|
2002-10-14 |
2005-11-03 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Diagnosis and treatment of disorders of collagen and elastin metabolism
|
|
US20040120937A1
(en)
|
2002-12-19 |
2004-06-24 |
Therapy Patent Corporation |
Blood therapy process
|
|
US7060795B2
(en)
*
|
2002-12-19 |
2006-06-13 |
Kimberly-Clark Worldwide, Inc. |
Wound care compositions
|
|
BR0317715A
(pt)
|
2002-12-27 |
2005-11-22 |
Angiotech Int Ag |
Composições e processos de uso de collajolie
|
|
US7785601B2
(en)
|
2002-12-31 |
2010-08-31 |
Sygnis Bioscience Gmbh & Co. Kg |
Methods of treating neurological conditions with hematopoietic growth factors
|
|
US20050214859A1
(en)
|
2003-03-03 |
2005-09-29 |
Dyax Corp. |
Peptides that specifically bind HGF receptor (cMet) and uses thereof
|
|
GB0305133D0
(en)
|
2003-03-06 |
2003-04-09 |
Sinvent As |
Product
|
|
RU2380356C2
(ru)
|
2003-03-24 |
2010-01-27 |
Актимис Фармасьютикалз, Инк. |
Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний
|
|
EP1622577A4
(en)
|
2003-04-17 |
2007-09-26 |
Univ Leland Stanford Junior |
PREVENTION OF NEUROGENESE DEFICITES WITH ANTI-INFLAMMATORY AGENTS
|
|
JP4662557B2
(ja)
|
2003-06-09 |
2011-03-30 |
レドックス−リアクティブ リエイジェンツ リミテッド ライアビリティー カンパニー |
酸化還元反応による血漿タンパク質の結合特異性の改変方法
|
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
|
DK2211183T3
(da)
|
2003-11-19 |
2013-05-13 |
Satoris Inc |
Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom
|
|
US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
|
WO2005106492A2
(en)
|
2004-04-30 |
2005-11-10 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
|
|
WO2006009179A1
(ja)
|
2004-07-23 |
2006-01-26 |
Kaneka Corporation |
水不溶性微粒子を除去した吸着材を充填した直接血液灌流用吸着器、および水不溶性微粒子を除去した直接血液灌流用吸着材の取得方法
|
|
US20090209615A1
(en)
|
2004-09-27 |
2009-08-20 |
Stuart Lipton |
Inhibitors of matrix metalloproteinases to treat neurological disorders
|
|
ES2434732T3
(es)
|
2004-12-15 |
2013-12-17 |
Janssen Alzheimer Immunotherapy |
Anticuerpos para beta-amiloide humanizados para su uso en mejorar la cognición
|
|
JP2008537736A
(ja)
|
2005-03-18 |
2008-09-25 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
抗原特異的ｔ細胞の操作に有用な組換えｍｈｃ分子
|
|
EP2517727A3
(en)
|
2005-09-29 |
2013-10-30 |
Caprion Proteomics USA, LLC |
Biomarkers for multiple sclerosis and methods of use thereof
|
|
US20090181008A1
(en)
|
2005-11-10 |
2009-07-16 |
Satoris, Inc. |
Methods of treating alzheimer's disease
|
|
WO2007062376A2
(en)
|
2005-11-21 |
2007-05-31 |
Florida Atlantic University |
Selective inhibition of matrix metalloproteinases
|
|
US7908090B2
(en)
|
2005-11-30 |
2011-03-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Signatures for human aging
|
|
US20090227673A1
(en)
|
2006-01-13 |
2009-09-10 |
Bao Ting Zhu |
Method and Composition for the Treatment of Parkinson's Disease
|
|
US10344095B2
(en)
|
2006-02-16 |
2019-07-09 |
University Of Kentucky Research Foundation |
CCR3 inhibition for ocular angiogenesis and macular degeneration
|
|
US8828977B2
(en)
|
2006-02-16 |
2014-09-09 |
Discogen, Llc |
Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
|
|
JP2009149524A
(ja)
|
2006-03-16 |
2009-07-09 |
Kyushu Univ |
アルツハイマー病の予防・治療剤
|
|
US20080026485A1
(en)
|
2006-04-18 |
2008-01-31 |
Wolfgang Hueber |
Antibody profiling for determination of patient responsiveness
|
|
EP2924440A3
(en)
|
2006-06-07 |
2016-03-09 |
Health Diagnostic Laboratory, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
|
US7851172B2
(en)
|
2006-07-25 |
2010-12-14 |
University Of Kentucky Research Foundation |
Biomarkers of mild cognitive impairment and alzheimer's disease
|
|
US7592009B2
(en)
*
|
2006-10-10 |
2009-09-22 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Polypeptide ligands for targeting cartilage and methods of use thereof
|
|
US8211310B2
(en)
|
2006-11-20 |
2012-07-03 |
Cytosorbents, Inc. |
Size-selective polymer system
|
|
WO2008106076A2
(en)
*
|
2007-02-27 |
2008-09-04 |
Merck & Co., Inc. |
Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples
|
|
WO2009008928A2
(en)
|
2007-04-13 |
2009-01-15 |
Stemnion, Inc. |
Methods for treating nervous system injury and disease
|
|
GB0710522D0
(en)
|
2007-06-01 |
2007-07-11 |
Royal Veterinary College The |
Drug delivery system comprising matrix metalloproteinase inhibitors
|
|
BRPI0815551A2
(pt)
|
2007-08-15 |
2015-02-18 |
Univ South Florida |
Tratamento através de hucbc de doença beta-amiloide
|
|
US8097645B2
(en)
|
2007-10-12 |
2012-01-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds for activating TGF-β signaling
|
|
US20090227018A1
(en)
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
|
US20100015235A1
(en)
|
2008-04-28 |
2010-01-21 |
Revalesio Corporation |
Compositions and methods for treating multiple sclerosis
|
|
US20100310609A1
(en)
|
2007-10-25 |
2010-12-09 |
Revalesio Corporation |
Compositions and methods for treatment of neurodegenerative diseases
|
|
JP5211071B2
(ja)
|
2007-12-06 |
2013-06-12 |
旭化成メディカル株式会社 |
血液処理用多孔質中空糸膜
|
|
CA2722658C
(en)
*
|
2008-04-28 |
2018-09-18 |
Richard L. Watson |
Compositions and methods for treating multiple sclerosis
|
|
US20110142848A1
(en)
|
2008-08-07 |
2011-06-16 |
Chung Leland W K |
Anti-beta-2-microglobulin agents and the use thereof
|
|
JP5651474B2
(ja)
|
2008-10-09 |
2015-01-14 |
オリエンタル酵母工業株式会社 |
β−アミロイド前駆体蛋白質由来マトリックスメタロプロテアーゼ−２インヒビターペプチドと組織メタロプロテアーゼ阻害物質との融合タンパク質
|
|
US20100124756A1
(en)
|
2008-10-10 |
2010-05-20 |
Sandip Ray |
Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
|
|
US20110117100A1
(en)
|
2008-11-03 |
2011-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for diagnosis, stratification and treatment of amyloidogenic diseases
|
|
US8778616B2
(en)
|
2009-05-26 |
2014-07-15 |
University Of Kentucky Research Foundation |
Method of using CCR3 binding agents to detect choroidal neovascularization
|
|
WO2017120461A1
(en)
|
2016-01-08 |
2017-07-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
|
|
US20160208011A1
(en)
|
2010-01-28 |
2016-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
|
|
WO2011094535A2
(en)
|
2010-01-28 |
2011-08-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers of aging for detection and treatment of disorders
|
|
US20110202284A1
(en)
|
2010-02-10 |
2011-08-18 |
Mcreynolds Cristopher |
Novel groups of biomarkers for diagnosing alzheimer's disease
|
|
RU2428997C1
(ru)
|
2010-03-01 |
2011-09-20 |
Федеральное государственное образовательное учреждение высшего профессионального образования Волгоградская государственная сельскохозяйственная академия |
Способ получения лечебных препаратов из пуповины плода
|
|
AR080698A1
(es)
|
2010-04-01 |
2012-05-02 |
Imclone Llc |
Anticuerpo o fragmento del mismo que especificamente enlaza la variante de csf -1r humano, composicion farmaceutica que lo comprende, su uso para la manufactura de un medicamento util para el tratamiento de cancer y metodo para determinar si un sujeto es candidato para tratamiento de cancer basado e
|
|
ES2706412T3
(es)
|
2010-05-04 |
2019-03-28 |
Five Prime Therapeutics Inc |
Anticuerpos que se unen a CSF1R
|
|
US9161968B2
(en)
|
2011-04-08 |
2015-10-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
|
|
WO2012149607A1
(en)
*
|
2011-05-03 |
2012-11-08 |
Commonwealth Scientific And Industrial Research Organisation |
Method for detection of a neurological disease
|
|
US9782457B2
(en)
|
2011-10-07 |
2017-10-10 |
Tissue Repair Company |
Flowable formulations for tissue repair and regeneration
|
|
RU2470677C1
(ru)
|
2011-10-19 |
2012-12-27 |
Надежда Михайловна Цулая |
Способ стимуляции репаративных и трофических процессов в коже
|
|
US20140294724A1
(en)
|
2011-10-24 |
2014-10-02 |
Intellect Neurosciences, Inc. |
Compositions and methods for treatment of proteinopathies
|
|
US20150079045A1
(en)
|
2012-02-13 |
2015-03-19 |
Wuyi Kong |
Nprcps, pfdncs and uses thereof
|
|
BR112014023200A2
(pt)
|
2012-03-20 |
2018-09-18 |
Albert Einstein College Of Medicine Of Yeshiva University |
uso de uma composição
|
|
US20130302322A1
(en)
|
2012-05-11 |
2013-11-14 |
Five Prime Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
|
|
RU2635560C2
(ru)
|
2012-10-29 |
2017-11-14 |
Чайна Петролеум Энд Кемикал Корпорейшн |
Способ адсорбционной десульфуризации углеводородов и реакторное устройство для его осуществления
|
|
EP2781523A1
(en)
|
2013-03-18 |
2014-09-24 |
Miltenyi Biotec GmbH |
Lipophilic oligonucleotide analogs
|
|
CA2930874A1
(en)
|
2013-11-26 |
2015-06-04 |
University Of North Texas Health Science Center At Fort Worth |
Personalized medicine approach for treating cognitive loss
|
|
US10905779B2
(en)
|
2013-12-09 |
2021-02-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening human blood products comprising plasma using immunocompromised rodent models
|
|
CN106163530A
(zh)
|
2013-12-09 |
2016-11-23 |
小利兰·斯坦福大学托管委员会 |
用于治疗衰老相关病症的方法和组合物
|
|
CA2945953A1
(en)
|
2014-04-16 |
2015-10-22 |
Blood Systems Research Institute |
Method and composition for conferring neuroprotection
|
|
EP3892315A1
(en)
|
2015-05-18 |
2021-10-13 |
The Board of Trustees of the Leland Stanford Junior University |
Methods and compositions for treating aging-associated impairments
|
|
EA201890020A1
(ru)
|
2015-06-15 |
2018-05-31 |
Зе Боард Оф Трастиз Оф Зе Леланд Стэнфорд Джуниор Юниверсити |
Способы и композиции для лечения ассоциированных со старением состояний
|